Ligand · VJZ
VJZ · 5-[4-(1,5-dimethylpyrazol-4-yl)-2-methyl-phenyl]-~{N}-(imidazo[1,2-a]pyridin-6-ylmethyl)-~{N}-methyl-1,3,4-oxadiazol-2-amine
VJZ, 5-[4-(1,5-dimethylpyrazol-4-yl)-2-methyl-phenyl]-~{N}-(imidazo[1,2-a]pyridin-6-ylmethyl)-~{N}-methyl-1,3,4-oxadiazol-2-amine (C23 H23 N7 O, 413.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every…
- Component
- VJZ
- Formula
- C23 H23 N7 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
VJZ in 2 structures; the first of them:
- 7OLS · MerTK kinase domain with type 1.5 inhibitor containing a di-methyl pyrazole group · VJZ A901 · binds LEU593, VAL601, ALA617, LYS619, PHE634, GLU637, ALA638, MET641 and 11 more
- 7OLS · Mertk kinase domain with type 1.5 inhibitor containing a di-methyl pyrazole group · VJZ A901 · binds VAL601, ALA617, PHE634, GLU637, ALA638, MET641, ILE650, LEU652 and 9 more
Residues it binds most
ALA 2, MET 2, PHE 2, LEU 2, VAL 2, ASP 2, GLU 2, ILE 2, PRO 2, LYS 1 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.